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Background: β2-microglobulin is a surrogate marker of middle-
molecule uremic toxins and serum β2-microglobulin levels are
associated with all-cause mortality in hemodialysis (HD)
patients.In this study, we investigated the impact of serum β2-
microglobulin levels on cardiovascular and infectious diseases in
chronic HD patients.
Methods: Prevalent HD patients were selected from the Clinical
Research Center registry for End Stage Renal Disease, a multicenter
prospective cohort study on dialysis patients in Korea. Patients were
categorized into three groups by tertiles of serum β2-microglobulin
levels as follows: Tertile 1, β2-microglobulin o23.47 mg/L; Tertile 2,
β2-microglobulin 23.47-32.24 mg/L; Tertile 3, β2-microglobulin
432.24 mg/L. Cox regression analysis was used to calculate the
adjusted hazard ratio (HR) for ﬁrst cardiovascular diseases or
infection related-hospitalizations.
Results: A total of 1,012 prevalent HD patients were included in
this study. The median follow-up period was 24 months. Multi-
variate Cox proportional hazard model showed that highest tertile
had signiﬁcantly increased risk of cardiovascular diseases related-
hospitalizations compared with the lowest tertile (HR: 1.68, 95%
CI: 1.05-2.67). The risk of infection related-hospitalizations was
signiﬁcantly increased in higher tertiles compared with lowest
tertile (Tertile 2; HR 1.66, 95% CI: 1.07-2.58, Tertile 3; 1.88, 95% CI,
1.23-2.88) after adjustment for clinical variables.Conclusions: Our data showed that the serum β2-microglobulin
levels were signiﬁcant predictor of clinical outcome for cardio-
vascular disease or infection in chronic HD patients.
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Purposes: To evaluate the mineral and bone disorders in children
with chronic kidney disease (CKD) stage I to V predialysis.
Methods: Pediatric subcohort of KNOW-CKD (KoreaN cohort
study for Outcome in patients With CKD) enrolled children
(younger than 20 years) with CKD stage I-V (pre-dialysis) from
ﬁve major pediatric nephrology centers in Korea and collected
medical data associated with CKD-mineral and bone disorder.
Results: Total number of 300 patients (male:female¼
199:101) was included in this study. Serum phosphorus (mean
7 standard deviation 4.8970.75, 4.670.83, 4.6370.85, 5.137
1.37, 5.3571.2 from CKD stage I to V, p¼0.0002), ﬁbroblast
growth factor (FGF)-23 (32.29742.04, 41.33741.00, 70.687
121.06, 67.9766.95, 121.747139.36, p¼0.0030) and the preva-
lence of hyperphosphatemia (8.51%, 10.64%, 25.53%, 25.53%,
29.79%, p¼0.010) increased as CKD progressed. Intact parathyr-
oid hormone (iPTH) increased (40.84740.37, 44.13720.2,
78.93765.21, 181.397183.86, 313.857324.95, po0.001) and
serum 1,25D3 level decreased (47.52721.32, 37.43712.26,
36.86725.97, 28.29715.81, 34.11721.34, po0.001) signiﬁ-
cantly as CKD aggravated. Serum iPTH (r¼0.608, po0.0001)
and FGF-23 (r¼0.4943, po0.0001) showed negative correla-
tion whereas 1,25D3 (r¼0.3288, o0.0001) showed positive
correlation with glomerular ﬁltration rate. FGF-23 showed posi-
tive correlation with serum phosphorus (r¼0.3342, po0.0001),
iPTH (r¼0.3214, po0.0001) and proteinuria (r¼0.3609,
po0.0001), and negative correlation with urine phosphorus
(r¼0.2597, p¼0.0006). The prevalence of patients with
increased alkaline phosphatase level increased signiﬁcantly as
CKD progressed (5.66%, 15.09%, 39.62%, 16.98%, 22.64%,
p¼0.042), which was due to increased prevalence of hyperpar-
athyroidism (po0.001). Active form vitamin D (0%, 3.77%, 11.88%,
40.74%, 68.89%, po0.0001), calcium (2.13%, 0%, 9.90%, 4.44%,
